Fatal Streptococcus equi subsp. ruminatorum Infection in a Man
To the Editor: Streptococcus equi belongs to the pyogenic group of streptococci and to group C of the Lancefi eld classifi cation. It consists of 3 subspecies of zoonotic agents rarely reported as human pathogens (1,2): S. equi subsp. equi, S. equi subsp. zooepidemicus, and S. equi subsp. ruminatorum. We report here a case of human infection caused by S. equi subsp. ruminatorum. (3) .
A 53-year-old man was admitted to an intensive care unit of our hospital (University Teaching Hospital, Montpellier, France) on April 28, 2006, with a high fever and in a comatose state. The day before, he had experienced headache and neck pain. He had been infected with HIV for 9 years but had not had an opportunistic infection. His ongoing HIV treatment consisted of ritonavir, lopinavir, abacavir, lamivudine, and co-trimoxazole; 3 weeks before admission, his blood CD4+ Tcell count was 133/μL, and viral load was 118,000 copies/mL. At the time of admission, his body temperature was 38.9°C, heart rate was 105 beats/min, and blood pressure was 55/35 mmHg. He exhibited a fi xed pupil in 1 eye, neck stiffness, and was nonresponsive. He had bilateral pulmonary infi ltrates and severe hypoxemia. Treatment consisted of mechanical ventilation, fl uid therapy, and norepinephrine. Laboratory investigations found the following: leukocyte count 9,600/mm 3 with 90% neutrophils, hemoglobin level 9.0 g/dL, platelet count 32,000/mm 3 , Creactive protein value 159 mg/L, and blood lactate concentration 3.2 mmol/ L. Computed tomographic scanning of the brain showed no hemorrhage or edema. Lumbar puncture produced turbid cerebrospinal fl uid (CSF) with 300 leukocytes/mm 3 (95% neutrophils), protein 5.6 g/L, glucose <0.1 mmol/L, and gram-positive cocci. Three sets of aerobic-anaerobic blood cultures and bronchial aspirates were sampled, and intravenous treatment with dexamethasone (10 mg/6 h/day), cefotaxime (2 g/4 h/day), and vancomycin (30 mg/kg/day) was initiated. On day 2, the hemodynamic state was stabilized, but brain death occurred.
All sets of aero-anaerobic blood cultures, CSF, and bronchial aspirate fl uid yielded the growth of a catalasenegative, β-hemolytic, gram-positive cocci belonging to the Lancefi eld group C of streptococci. Antimicrobial susceptibility testing showed a bacterium fully susceptible to antibiotics tested. MICs of penicillin, amoxicillin, and cefotaxime were 0.047, 0.125, and 0.125 mg/L, respectively. The isolates were identifi ed as S. equi by using the Vitek2 system, rapid ID32 STREP, and API 20 STREP strips (bioMérieux, Marcy l'Etoile, France), but phenotype was inconclusive for subspecies identifi cation. The strains were identifi ed as S. equi subsp.
zooepidemicus by Vitek2, but aesculin was not hydrolyzed, and D-ribose fermentation was noted, as previously described for S. equi subsp. ruminatorum. 16S rRNA gene-based identifi cation was performed as previously described (4) on strain ADV 6048.06 from blood. The 1,396-bp sequence (GenBank accession no. EF362949) was compared with databases by using the BLAST program (5) (Figure) .
S. equi subsp. equi and S. equi subsp. zooepidemicus are zoonotic agents implicated in diverse animal infections such as strangles, mastitis, abscesses, wounds, and respiratory and uterine infections. Human infections caused by S. equi subsp. equi, and S. equi subsp. zooepidemicus included outbreaks of foodborne diseases (6,7), meningitis, septicemia, arthritis, pneumonia, glomerulonephritis, and streptococcal toxic shock syndrome, in both immunocompromised and immunocompetent patients (1,2,8,9 ). S. equi subsp. ruminatorum was described in 2004 in domestic sheep and goats with mastitis (3). More recently, it was isolated during severe infections in spotted hyenas and zebras (10) . No human isolate has been reported to date. Moreover, none of the 3 subspecies of S. equi has been isolated from HIV-infected patients. The current case underlines the conclusion that molecular identifi cation of S. equi subsp. ruminatorum is essential. S. equi subsp. ruminatorum could have been underestimated due to its potential misidentifi cation as S. equi subsp. zooepidemicus by phenotypic tools. Despite the rare occurrence of group C streptococci in human infections, a high death rate is reported for invasive infections (7-9). S. equi subsp. zooepidemicus produce superantigen exotoxin that may have been implicated in the pathogenesis of fatal infection (2); S. equi subsp. ruminatorum should also be investigated for potential virulence factors for humans.
Epidemiologic investigations were unsuccessful in tracing the patient's infection to an animal source. The respiratory tract, from which S. equi subsp. ruminatorum was recovered in pure culture, could be considered the most probable portal of entry.
The mode of S. equi subsp. ruminatorum transmission to humans remains unknown. More information is needed on its reservoirs, but they likely resemble those of S. equi subsp. equi, and S. equi subsp. zooepidemicus (2,6,7). Prevention of human infections due to S. equi should include frequent microbiologic sampling of lactating animals and control measures for unpasteurized dairy products (7) . Better characterization of underlying conditions that increase risk of invasive S. equi infections is also needed. This knowledge could help defi ne high-risk 
Rabies Prophylaxis for Pregnant Women
To the Editor: Rabies poses a 100% risk for death to pregnant women and an indeterminate risk to the fetus (1,2). Although a theoretical risk exists for adverse effects from rabies immune globulin and killed rabies virus vaccines, several studies assessing the safety of this treatment have failed to identify these risks (3) (4) (5) (6) . Indeed, the consensus is that pregnancy is not a contraindication to rabies postexposure prophylaxis (PEP) (7) . Despite this concensus, healthcare providers resist treating pregnant women with rabies PEP. We describe a case of a pregnant woman with uncertain rabies exposure.
A 35-year-old pregnant woman (at 34 weeks gestation) sought treatment 3 weeks after being exposed to a bat. The patient reported awakening at 3:00 AM to fi nd a bat fl ying in her bedroom. She attempted to confi ne the bat to 1 section of the home and then called for help. A relative trapped and retrieved the bat, then disposed of the animal without further incident. The patient denied being bitten by the bat, and she had no obvious bite marks after the event. Initially, the patient sought information from online resources, her primary care physician, and her obstetrician. She was uncertain whether rabies PEP was warranted, given what she believed to be the low probability of the bat being rabid and the low likelihood of her having had direct exposure to the bat. The patient did express concern about the safety of rabies PEP in pregnant women. Because no unequivocal recommendations were made by either her primary care physician or obstetrician, she sought further advice from the Infectious Diseases Department at the University of Michigan on how best to proceed.
The 1999 recommendations of Centers for Disease Control and Prevention Advisory Committee on Immunization Practices state, "... postexposure prophylaxis can be considered for persons who were in the same room as the bat and who might be unaware that a bite or direct contact had occurred ..." (8) . Bat bites may not be apparent when they occur, even with careful examination. In fact, most of the recent human rabies patients have no known history of exposure to a rabid animal (9, 10) . Of the 21 cases of bat-associated rabies in the United States during 1980-1999, 12 (57%) occurred in persons with apparent bat contact but no detectable bites (8) . Our patient woke up with a bat fl ying in her room and did not know how long it had been there. The best course of action would have been to test the bat for rabies. However, because the animal had already been disposed of, laboratory testing for rabies was not possible. Furthermore, given that 5%-9% of bats tested in Washtenaw County, Michigan, are positive for rabies (www.mdch.state.mi.us/pha/epi/cded/ cd/batcoframe.htm), the exposure risk was not insignifi cant. Therefore, it
